Seattle, WA, United States of America

Rene H Levy

This inventor holds 2 USPTO granted patents. Top assignee: Laboratoires Biocodex. Active years: 1986-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rene H Levy. Retrieved from https://idiyas.com/inventor/rene-h-levy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1986-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Rene H Levy

Introduction

Rene H Levy is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of epilepsy and pseudo-membranous colitis. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

One of Levy's latest patents is a method for treating epilepsy. This method involves administering stiripentol to patients who are already under antiepileptic treatment with standard drugs. The goal is to alleviate or prevent the side effects associated with these treatments. Additionally, he has developed an antiepileptic composition that includes stiripentol. Another significant patent focuses on preventing or treating pseudo-membranous colitis in patients undergoing antibiotic treatment. This method utilizes Saccharomyces yeasts to provide relief.

Career Highlights

Levy is associated with Laboratoires Biocodex, where he continues to innovate and develop new medical treatments. His work is characterized by a commitment to improving patient outcomes through scientific research and practical applications.

Collaborations

Levy has collaborated with notable colleagues, including Bernard M Hublot and Joan S Lockard, who contribute to his research efforts and innovations.

Conclusion

Rene H Levy's contributions to medical science through his patents demonstrate his dedication to improving healthcare. His innovative methods for treating epilepsy and pseudo-membranous colitis highlight the importance of research in developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…